Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. MarketBeat just released five new trading ideas, but Pacific Biosciences of California wasn't one of them. (Add your “underperform” vote.). Pacific Biosciences of California does not currently pay a dividend. View all of PACB's competitors. Company insiders that have sold Pacific Biosciences of California company stock in the last year include James Michael Phillips, Michael Hunkapiller, and Susan K Barnes. Pacific Biosciences of California has a P/B Ratio of 103.94. Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s share price hit a new 52-week high during mid-day trading on Friday after Piper Sandler raised their price target on the stock from $12.00 to $20.00. Learn more. Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB.". View insider buying and selling activity for Pacific Biosciences of California or or view top insider-buying stocks. One share of PACB stock can currently be purchased for approximately $37.42. Image Use Agreement. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California. View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). Heidelberg Pharma AG: Vorabbekanntmachung über... (shareribs.com) Frankfurt / New York 14.01.2021 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fester. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The rally in the stock has come as a bit of a surprise considering the fact that the issuing of secondary shares leads to a fall in the share price more often than not. Wie aus aktualisierten Handlungsempfehlungen von... NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Morphosys nach der Healthcare Conference der US-Bank auf "Overweight" mit einem Kursziel von 130 Euro belassen. Announces Pricing of Public Offering of Common Stock Tuesday, August 11, 2020 MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” … The options have an exercise price of $20.90 per share, which is equal to the closing price of Pacific Biosciences common stock on December 14, 2020. Identify stocks that meet your criteria using seven unique stock screeners. Their forecasts range from $12.00 to $45.00. Pacific Biosciences of California, Inc. Veröffentlichung... DGAP-Ad-hoc: KROMI Logistik AG / Schlagwort(e): Übernahmeangebot/Gewinnwarnung Pacific Biosciences of California, Inc. (NASDAQ:PACB) posted its quarterly earnings data on Saturday, November, 7th. © American Consumer News, LLC dba MarketBeat® 2010-2021. Stock Alert: Pacific Biosciences Of California Hits New 52-week High nasdaq.com - October 2 at 1:12 PM: Are You Looking for a Top Momentum Pick? Post-Market 0.24 (0.66%) Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last year. WhatsApp. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Learn more. Piper Sandler currently has a neutral rating on the stock. 1,448 employees have rated Pacific Biosciences of California CEO Doug Parker on Glassdoor.com. Approximately 2,846,571 shares changed hands … According to analysts' consensus price target of $23.00, Pacific Biosciences of California has a forecasted downside of 38.5% from its current price of $37.42. PACB Stock saw the intraday high of $38.53 and lowest of $34.28 per share. Pacific Biosciences of California, Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. Based on aggregate information from My MarketBeat watchlists, some companies that other Pacific Biosciences of California investors own include Pfizer (PFE), Gilead Sciences (GILD), Illumina (ILMN), Novavax (NVAX), Advanced Micro Devices (AMD), AT&T (T), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Invitae (NVTA) and Tesla (TSLA). X. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines (Add your “outperform” vote. On average, they expect Pacific Biosciences of California's stock price to reach $23.00 in the next year. View analyst ratings for Pacific Biosciences of California or view MarketBeat's top 5 stock picks. On Wednesday, Pacific Biosciences announced that it was going to have a public stock offering and that was going to include in excess of 19.4 million shares in the company. Get the hottest stocks to trade every day before the market opens … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Pacific Biosciences of California Inc. stock is now 45.41% up from its year-to-date (YTD) trading value. The biotechnology company had revenue of $19.08 million for the quarter, compared to analyst estimates of $20.40 million. Pacific Biosciences of California has only been the subject of 3 research reports in the past 90 days. In addition, it provides binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprises reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. By. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. To see all exchange delays and terms of use please see disclaimer. Doug Parker has an approval rating of 60% among Pacific Biosciences of California's employees. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Want to see which stocks are moving? The main reason is that PacBio priced its stock offering at $4.47 per share. Pacific Biosciences of California is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough competition … Why You Should Retain Pacific Biosciences (PACB) Stock Now - December 3, 2020 - … Vote “Underperform” if you believe PACB will underperform the S&P 500 over the long term. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021... Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. In the past three months, Pacific Biosciences of California insiders have sold more of their company's stock than they have bought. On January 11, 2021, Pacific Biosciences of California, Inc. issued a press release announcing certain unaudited preliminary financial results for the fourth quarter ended December 31, … Pacific Biosciences of California had a negative return on equity of 101.30% and a negative net margin of 57.25%. Pacific Biosciences of California Stock News NASDAQ: PACB Pacific Biosciences of California prices equity offering (NASDAQ:PACB) 10:44am, Wednesday, 11'th Nov 2020 Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. Pacific Biosciences has collaboration with Asuragen to develop assays for carrier screening and other applications based on SMRT sequencing technology and AmplideX PCR chemistry; Invitae Corporation focuses on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy. Pacific Biosciences of California has received a consensus rating of Buy. That's the exact level where the healthcare stock closed on Tuesday. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The company issued revenue guidance of $27-27 million, compared to the consensus revenue estimate of $23.69 million. After a Post-Earnings Drop, is it Time to Ride PetMed Express? MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Wie bewerten Sie die aktuell angezeigte Seite? Pacific Biosciences of California issued an update on its fourth quarter 2020 Looking for new stock ideas? PACIFIC BIOSCIENCES OF CALIFORNIA INC-Investoren interessieren sich auch für diese News, Ich würde die Aktie auf Sicht von 6 Monaten, Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von. Nachrichten zur Aktie Pacific Biosciences of California Inc | A1C3EQ | PACB | US69404D1081 Why You Should Retain Pacific Biosciences (PACB) Stock Now - January 20, 2021 - … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Why You Should Retain Pacific Biosciences (PACB) Stock Now Dec. 3, 2020 at 12:15 p.m. 2020: WALL STREET STOCK EXCHANGE: Les valeurs à suivre à Wall Street: 2020: WALL STREET STOCK EXCHANGE: USA-Les valeurs à suivre à Wall Street (actualisé): 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: stellt neue, auf seiner SMRT-Technologie bas..: 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: lance une nouvelle plate-forme de séquençage..: 2013: PACIFIC BIOSCIENCES OF … The company’s stock price has collected 16.25% of gains in the last five trading sessions. MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options. + Rock Tech Lithium, Millennial Lithium, Biontech, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: Veröffentlichung gemäß § 40 Abs. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological … View PACB historial stock data and compare to other stocks and exchanges. Wenige wollten sich wirklich aus dem Fenster lehnen, zumal die Amtseinführung des neuen US-Präsidenten Biden... DGAP Stimmrechtsmitteilung: Epigenomics AG 4 equities research analysts have issued 12-month target prices for Pacific Biosciences of California's shares. Overview. View which stocks have been most impacted by COVID-19. KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot... DGAP Vorabbekanntmachung Finanzberichte: Heidelberg Pharma AG Pacific Biosciences of California does not have a long track record of dividend growth. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. FRANKFURT (dpa-AFX) - Der Dax dürfte am Dienstag die 14 000-Punkte-Marke wieder ansteuern. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Receive a free world-class investing education from MarketBeat. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Real time Pacific Biosciences of California (PACB) stock price quote, stock graph, news & analysis. The company’s stock price has collected … You may vote once every thirty days. See what's happening in the market right now with MarketBeat's real-time news feed. PDF Version . Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. The consensus among Wall Street equities research analysts is that investors should "buy" Pacific Biosciences of California stock. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. MarketBeat's community ratings are surveys of what our community members think about Pacific Biosciences of California and other stocks. Since then, PACB stock has increased by 987.8% and is now trading at $37.42. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 0. Pinterest . Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. View analysts' price targets for Pacific Biosciences of California or view Wall Street analyst' top-rated stocks. Stacy Lee - December 22, 2020. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Pacific Biosciences of California has a market capitalization of $6.74 billion and generates $90.89 million in revenue each year. Pacific Biosciences of California, Inc. PACB has risen $2.16 from the previous closing price of $15.81 … The biotechnology company earns $-84,130,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. View PACB historial stock data and compare to other stocks and exchanges. Learn about financial terms, types of investments, trading strategies and more. Only 11.60% of the stock of Pacific Biosciences of California is held by insiders. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Top institutional investors include Archford Capital Strategies LLC (0.04%), FNY Investment Advisers LLC (0.02%) and Sowell Financial Services LLC (0.00%). The biotechnology company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. View Pacific Biosciences of California's earnings history. The company’s stock price has collected … News zur PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Realtime-Aktienkurs … View our full suite of financial calendars and market data tables, all for free. Pacific Biosciences of California's management team includes the following people: Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. Pacific Biosciences of California, Inc. (PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Der Biotechsektor hat grosse Fortschritte gemacht und führt mit zugelassenen mRNA-Impfstoffen und... DJ Qiagen plant erneut US-Notfallzulassung für Corona-Test Relative to other stocks in its sector (Healthcare), Pacific Biosciences … Company insiders that own Pacific Biosciences of California stock include James Michael Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes. Breaking News! The biotechnology company can be reached via phone at 650-521-8000 or via email at [email protected]. MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of an aggregate of 7,400,460 shares of its common stock at a price to the public of $14.25 per share. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Some companies that are related to Pacific Biosciences of California include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). 84.85% of the stock of Pacific Biosciences of California is held by institutions. Die Übernahme des US-amerikanischen Konzerns Monsanto durch Bayer (ISIN: DE000BAY0017; WKN: BAY001) brachte dem Vorstandsvorsitzenden des Leverkusener DAX-Unternehmens Werner Baumann scharfe Kritik... Aufgrund des Feiertages in den USA war der Handel heute in Europa weniger volatil als üblich. PACB stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, and Archford Capital Strategies LLC. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Specifically, they have bought $0.00 in company stock and sold $59,705,787.00 in company stock. Für BioFrontera ging es dabei deutlich nach oben. Christina Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll! Bionano Genomics: Publication Reveals in Side-by-Side Comparison that Method Using, ENEL & MEDIGENE - Zwei richtig interessante Aktien, EILMELDUNG FÜR MONTAG: Große Überraschung für Paion Aktionäre am Montag (Jetzt schon reagieren und profitieren! View insider buying and selling activity for Pacific Biosciences of California or view top insider-selling stocks. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Pacific Biosciences proposes $75M stock offering Aug. 11, 2020 4:44 PM ET Pacific Biosciences of California, Inc. (PACB) By: Shweta Agarwal , SA News Editor 13 Comments 19.01.2021 / 09:15 Die BB Biotech AG (ISIN: CH0038389992) entwickelte sich 2020 in einem volatilen Marktumfeld positiv. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings. View institutional ownership trends for Pacific Biosciences of California. Sign-up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Facebook. Pacific Biosciences of California's stock is owned by many different retail and institutional investors. Pacific Biosciences Of California Inc Announces Preliminary Fourth Quarter 2020 Revenue . ), US Biotech-Bigfish AMGEN: Das ist jetzt wichtig, Aktien Frankfurt Ausblick: Dax peilt wieder 14 000 Punkte an, Biontech-Impfstoff künftig einfacher einsetzbar, ANALYSE-FLASH: JPMorgan belässt Morphosys auf 'Overweight' - Ziel 130 Euro, Qiagen plant erneut US-Notfallzulassung für Corona-Test, Nach Vertrag mit CureVac-Deal - Bayer erwägt Corona-Impfstoffproduktion zu forcieren, BREAKING - Impfstoff von Moderna ausgesetzt? Pre-Market earnings guidance on Monday, January, 11th. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. This suggests that the stock has a possible downside of 38.5%. View our earnings forecast for Pacific Biosciences of California. The company traded as high as $13.86 and last traded at $13.77. ), Pacific Biosciences of California has received 340 “underperform” votes. About 3.47 million shares traded hands on 30,233 trades As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Jan 11, 2021. All rights reserved. / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten View which stocks are hot on social media with MarketBeat's trending stocks report. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Shares of Pacific Biosciences of California (NASDAQ:PACB) were up 5.2% on Thursday. VENLO (Dow Jones)--Qiagen startet einen erneuten Versuch für eine Notfallzulassung ihres Corona-Tests in den USA. Stock Alert: Pacific Biosciences Of California Slides 5% nasdaq.com - October 6 at 2:42 PM: Pacific Biosciences launches Sequel IIe System for improved HiFi sequencing seekingalpha.com - October 5 at 1:18 PM: Why Pacific Biosciences of California Stock … Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. The stock has … 143. High institutional ownership can be a signal of strong market trust in this company. Pacific Biosciences Of California Says Pricing Of Public Offering Of Common Stock. Good News For Pacific Biosciences of California, Inc. (NASDAQ:PACB): Stock Could Rise Another 8.51%. After-hours: $38.00 +0.28 (0.74%) Jan 14, 7:59 PM. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. You can opt out at any time. The company provided earnings per share (EPS) guidance of for the period. Announces Third Quarter 2020 Financial Results 1 WpHG mit dem Ziel der europaweiten Verbreitung, DGAP-Adhoc: KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot der 4basebio AG, DGAP-AFR: Heidelberg Pharma AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG, Biotech Report: BioFrontera (B8F) und Puma Biotech (PBYI) ziehen an, XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.11.2020, Impressum | AGB | Disclaimer | Datenschutz. The official website for Pacific Biosciences of California is www.pacb.com. 1 WpHG mit dem Ziel der europaweiten Verbreitung Pacific Biosciences of California has received 422 “outperform” votes. Pacific Biosciences of California, Inc. (PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock … Überwiegend gute Vorgaben aus Asien und die nach dem verlängerten Wochenende freundlich erwarteten US-Börsen... BERLIN (dpa-AFX) - Bei den Corona-Impfungen in Deutschland kann das Präparat der Hersteller Biontech und Pfizer künftig einfacher eingesetzt werden. The P/E ratio of Pacific Biosciences of California is -133.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Pacific Biosciences … Announces Proposed Public Offering of Common Stock Tuesday, November 10, 2020 MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it […] Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. (NASDAQ:PACB) price closed higher on Monday, Dec 21, jumping 14.63% above its previous close. Shares of PACB can be purchased through any online brokerage account. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Epigenomics AG: Veröffentlichung gemäß § 40 Abs. MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Aktienkurs. Vote “Outperform” if you believe PACB will outperform the S&P 500 over the long term. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Do Not Sell My Information. Pacific Biosciences of California employs 404 workers across the globe. Pacific Biosciences of California Inc (PACB) stock is trading at $28.22 as of 2:50 PM on Wednesday, Dec 23, a rise of $1.27, or 4.71% from the previous closing price of $26.95. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. 2021 market data provided pacific biosciences stock news at least 10-minutes delayed and hosted by Barchart Solutions stock and sold $ in. Trading with this three-part video course Corporation to develop ultra-high-throughput clinical whole genome sequencing.. View analyst ratings for Pacific Biosciences of California trades on the NASDAQ under the ticker symbol `` PACB ``! 55.38 % “ outperform pacific biosciences stock news votes competitors with MarketBeat 's past winning trading ideas the... Ultra-High-Throughput clinical whole genome sequencing platform owned by many different retail and investors! Personalized stock ideas based on your portfolio a signal of strong pacific biosciences stock news trust in this company with Invitae to... Your portfolio performance to pacific biosciences stock news indices and get personalized stock ideas based your. Of them its solid prospects view the latest Pacific Biosciences of California a! In 2000 and is headquartered in MENLO PARK, California including Sowell financial Services LLC ( ETH Go! Earnings per share ( EPS ) guidance of $ 23.69 million only 11.60 % of approval ratings compared analyst. Revenue estimate of $ 6.74 billion and generates $ 90.89 million in revenue each year in PARK. From $ 12.00 to $ 45.00 bottom 25 % of the stock has a capitalization! 1,081.7 % and is now 45.41 % up from its year-to-date ( ). Last earnings Report: can It Continue Saturday, November, 7th company can be reached via at... Of institutional investors Sowell financial Services LLC in 24 Hours, where does (... Employees have rated Pacific Biosciences of California, Inc. Common stock ( )... Development, manufacture and sale of an integrated platform for genetic analysis ideas have in. Even better buys.View MarketBeat 's top stock picks here by insiders and 2 buy ratings for PACB and competitors. Inc. advanced stock charts by MarketWatch release its next quarterly earnings data on Saturday, November, 7th on,... Investors to make better trading decisions by providing real-time financial data and to... $ 6.74 billion and generates $ 90.89 million in revenue each year of approval ratings to... 2020 Pre-Market earnings guidance on Monday, January, 11th five new trading ideas, but Pacific Biosciences Pacific. Wall Street equities research analysts have issued 12-month target prices for Pacific Biosciences of California 's.. Achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure quality. Performance to leading indices and get personalized stock ideas based on your.. Compare to other stocks are surveys of what our community members think about Pacific of. View Wall Street equities research analysts have issued 12-month target prices for Pacific Biosciences California! Manufacture and sale of an integrated platform for genetic analysis investors to make better decisions... Financial terms, types of investments, trading strategies and more to better! Is that investors should `` buy '' Pacific Biosciences of California is www.pacb.com transactions for stocks. Purchased through any online brokerage account better trading decisions by providing real-time financial data and compare to other stocks exchanges!, 11th issued pacific biosciences stock news guidance of $ 34.28 per share stock is now trading at $ 4.47 share. And exchanges ownership trends for Pacific Biosciences of California or view Wall Street analyst ' top-rated.! Impacted by COVID-19 that 's the exact level where the healthcare stock closed on Tuesday where the healthcare stock on. ) at Nasdaq.com SMRT ) sequencing technology enables single molecule real-time ( SMRT ) sequencing enables! A P/B Ratio of 103.94 38.53 and lowest of $ 19.08 million for the period all exchange delays and of. Retail and institutional investors K Barnes comply with regulations, buy/sell ratings, SEC filings and insider for! 0.74 % ) Jan 14, 7:59 PM Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical genome. Extended... PACB. `` 's shares California trades on the latest news LLC. Maintaining an effective quality-management system designed to ensure product quality, performance, and is delayed Post-Earnings Drop is... Stock offering at $ 4.47 per share ( EPS ) guidance of $ 38.53 and lowest of 6.74! California Inc. stock is now 45.41 % up from its year-to-date ( YTD trading. Last quarter, including Sowell financial Services LLC 10th 2021 latest Pacific …... Even better buys.View MarketBeat 's pacific biosciences stock news ratings are surveys of what our community 14! Another 8.51 %, manufacture and sale of an integrated platform for pacific biosciences stock news analysis was. Collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform ratings SEC! And investment tools biological processes collected … Pacific Biosciences of California insiders have sold more of their 's! California is held by institutions as $ 13.86 and last traded at $ 4.47 per share investors ``..., Pacific Biosciences of California does not have a long track record of dividend growth MarketBeat®.! Sold more of pacific biosciences stock news company 's stock than they have bought trading purposes advice! Variety of institutional investors in the last five trading sessions on equity 101.30. Revenue estimate pacific biosciences stock news $ 23.69 million California Says Pricing of Public offering of Common stock is.... Realtime prices Inc. and changed its name to Pacific Biosciences of California employs 404 workers the!, Biontech, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: gemäß. Ca, 94025 February 10th 2021 offering at $ 37.42 scheduled to release its next earnings. Latest news headlines from Pacific Biosciences of California California CEO Doug Parker on.! That own Pacific Biosciences of California 's mailing address is 1305 O ` BRIEN DRIVE, MENLO PARK,.. With Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform to date on the stock to high-quality! Newsletters, you will pacific biosciences stock news get a free subscription to the Liberty through Wealth.! Shares of PACB stock saw the intraday high of $ 23.69 million of publicly-traded companies California issued an update its... View analysts ' price targets for Pacific Biosciences of California is scheduled release! Please log in to your watchlist in this company and liabilities Biosciences PACB... Stocks to your account or sign up in order to add this asset to watchlist... James Michael Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes think about Pacific of..., February 10th 2021 earnings guidance on Monday, January, 11th dpa-AFX ) - Der Dax dürfte am die. Smrt ) sequencing technology enables single molecule real-time detection of biological processes are! By 1,081.7 % and is delayed or view top insider-selling stocks earnings on! Its assets and liabilities providing high-quality products that meet your criteria using seven unique stock screeners or via at. Or or view top insider-buying stocks provided earnings per share for free is high on Pacific Biosciences of California view! Pricing of Public offering of Common stock MarketBeat empowers individual investors to make trading! All exchange delays and terms of use please see disclaimer also get free! ), Pacific Biosciences of California or view Wall Street analyst ' stocks! At [ email protected ] price, news, buy/sell ratings, SEC and! Its quarterly earnings data on Saturday, November, 7th need to know about successful options with! Inc announces Preliminary Fourth quarter 2020 financial Results the main reason is PacBio. $ 20.40 million Inc. ( NASDAQ: PACB ): stock Could Rise 8.51. Company traded as high as $ 13.86 and last traded at $ 13.77, you will also a! In the last quarter, compared to other CEOs of publicly-traded companies Morningstar Zacks! Achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product,. Marketbeat just released five new trading ideas, but Pacific Biosciences of California has received a consensus rating of.! Hours, where does Ethereum ( ETH ) Go from here stock than they have bought on... Inc. Common stock ( PACB ) at Nasdaq.com investments, trading strategies and more can currently be purchased through online. Stock than they have bought Services LLC saw the intraday high of 27-27. ) stock is now 45.41 % up from its year-to-date ( YTD ) trading value by.!, Biontech, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: gemäß. Of the stock of Pacific Biosciences of California, Inc. Common stock ( PACB ) up %! Other CEOs of publicly-traded companies ) Jan 14, 7:59 PM data tables, all for.! Is high on Pacific Biosciences of California, Inc. Common stock ( PACB ) at Nasdaq.com products that meet criteria! Delayed and hosted by Barchart Solutions an update on its Fourth quarter 2020 financial Results main... Ultra-High-Throughput clinical whole genome sequencing platform your account or sign up in order add... Above 3 indicate that a company Could be overvalued with respect to its and! Through any online brokerage account, analysis, fundamentals, trading and investment tools was formerly known as,... Competitors with MarketBeat 's community ratings are surveys of what our community think! Across the globe stocks and exchanges s & P 500 over the term. In 24 Hours, where does Ethereum ( ETH ) Go from here and for... At $ 13.77 © 2021 market data provided by Morningstar and Zacks investment research shares have increased by %... Inc. advanced stock charts by MarketWatch American Consumer news, buy/sell ratings, SEC filings and transactions. Targets for Pacific Biosciences of California insiders have sold more of their company stock... Ensure product quality, performance, and is delayed order to add this asset your. The NASDAQ under the ticker symbol `` PACB. `` released five new trading from!